Dexrazoxane Intravenous and Mestinon (Pyridostigmine Extended-Release Tablets)
Determining the interaction of Dexrazoxane Intravenous and Mestinon (Pyridostigmine Extended-Release Tablets) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: pyridostigmine
Brand name: Mestinon, Mestinon Timespan, Regonol
Synonyms: Mestinon
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Mestinon (Pyridostigmine Liquid)
- Dexrazoxane Intravenous-Mestinon (Pyridostigmine Tablets)
- Dexrazoxane Intravenous-Mestinon Timespan
- Dexrazoxane Intravenous-Metadate ER
- Dexrazoxane Intravenous-Metaderm Mild
- Dexrazoxane Intravenous-Metaderm Regular
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextenza Insert
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextenza intraocular
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextran 40
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextran 70 6% in 5% Dextrose high molecular weight
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextran 75
- Mestinon (Pyridostigmine Extended-Release Tablets)-Dextran high molecular weight